Science and Research

The science and research behind psychedelics, including their potential therapeutic uses.

Illustration of psychedelic future where the war on drugs continues. Two thugs stand in the foreground looking away from the viewer

The War on Drugs: A Look Back and the Path Forward with MAPS

In the mid-1980s, America was deeply entrenched in its War on Drugs. The media was saturated with sensationalized headlines about the dangers of drug use and trade. One such article, titled “The Losing War Against ‘Designer Drugs’,” was featured in the June 24th, 1985 issue of Business Week. The article discussed the cat-and-mouse game of […]

The War on Drugs: A Look Back and the Path Forward with MAPS Read More »

Psychedelic female face

New study provides insights into the neurophysiological basis of psilocybin-induced alterations in consciousness

New research published in iScience provides unique insights into how psilocybin alters brain activity during psychedelic experiences. The findings suggest that while the overall activity of the brain becomes more chaotic during the psychedelic state, the brain’s ability to maintain complex interactions in response to external stimulation is not affected. Psilocybin is a naturally occurring

New study provides insights into the neurophysiological basis of psilocybin-induced alterations in consciousness Read More »

MDMA and Amphetamine molecule diagrams

Positive Follow-Up Study on MDMA-Assisted Therapy for Treatment of PTSD

SAN JOSE, Calif., April 5, 2023—MAPS Public Benefit Corporation (“MAPS PBC”), a clinical-stage company dedicated to changing the way mental health conditions are treated, announced positive topline results from an observational follow-up study evaluating the long-term safety and efficacy of MDMA-assisted therapy for post–traumatic stress disorder (“PTSD”). Preliminary findings show that participants in this study demonstrated a

Positive Follow-Up Study on MDMA-Assisted Therapy for Treatment of PTSD Read More »

Matthew Johnson, Ph.D. of Johns Hopkins

The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew Johnson

Matthew W. Johnson, Ph.D. is the Susan Hill Ward Professor in Psychedelics and Consciousness and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. Psychedelic research is enjoying a renaissance. Recent studies have shown that psychedelic drugs like LSD and psilocybin seem to be a safe and effective method for treating conditions like depression, anxiety,

The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew Johnson Read More »

Illuminated neural pathways represent neuro plasticity from mystical psychedelic experiences

Mystical and Insightful Psychedelic Experience May Improve Mental Health

Summary: Recent studies have explored the use of psychedelics for the treatment of a range of mental health disorders. A new study reveals more insightful and mystical “trips” while exposed to psychedelics may be linked to an enduring reduction of symptoms for those with anxiety and depression. Source: Ohio State University A more mystical and

Mystical and Insightful Psychedelic Experience May Improve Mental Health Read More »

Jordan Sloshower MD

Blinding in Clinical Trials Investigating Psychedelic Medicine Remains Difficult

Pharmacy Times interviewed Jordan Sloshower, MD, MSc, a clinical instructor of psychiatry at the Yale Department of Psychiatry, a member of Chacruna’s Council for the Protection of Sacred Plants, a clinical investigator in MAPS’ Expanded Access Program, a trainer with Usona Institute, co-director of West Rock Wellness, PLLC, and a member of the Board of

Blinding in Clinical Trials Investigating Psychedelic Medicine Remains Difficult Read More »

Scott Barry Kaufman standing in front of a stone wall

The Scientific Psychedelics Revolution and Embracing Mortality

Roland Griffiths & David Yaden || An Ode to Joy Scott Barry Kaufman is a cognitive scientist and humanistic psychologist exploring the mind, creativity, and the depths of human potential. He is a professor at Columbia University and founder and director of the Center for Human Potential. Dr. Kaufman has taught at Columbia University, Yale,

The Scientific Psychedelics Revolution and Embracing Mortality Read More »

Prior Positive Results Confirmed in MAPS-Sponsored, Philanthropy-Funded Phase 3 Trial

MAPS Achieves Major Milestone: Confirmatory Phase 3 Trial of MDMA-Assisted Therapy is Successful

Prior Positive Results Confirmed in MAPS-Sponsored, Philanthropy-Funded Phase 3 Trial The nonprofit Multidisciplinary Association for Psychedelic Studies’ (MAPS) clinical research program has achieved an important milestone: a successful confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD). The clinical research program that began in 1992 has been sponsored by the nonprofit MAPS

MAPS Achieves Major Milestone: Confirmatory Phase 3 Trial of MDMA-Assisted Therapy is Successful Read More »

Scroll to Top